Stereotaxis, Inc. (NASDAQ:STXS)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Recs

0
Player Avatar OPA11111 (75.76) Submitted: 7/13/2010 11:34:46 AM : Outperform Start Price: $3.68 STXS Score: -113.47

The technology of the magnetic pulling of the catheter vs pushing makes so much sense that only management can hold them down. Now that they are assembling a world class marketing team they are off to the races.

Featured Broker Partners


Advertisement